Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fagan

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
Talanta|October 31, 2008
Modification of micro-cantilever sensors with sol-gels to enhance performance and immobilize chemically selective phasesB C Fagan, C A Tipple, Z Xue, et al.
Annals of Emergency Medicine|May 29, 2012
A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic strokeDenise M Boudreau, Greg Guzauskas, Kathleen F Villa, et al.
Journal of Hypertension|October 12, 2014
Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic strokeAhmed Alhusban, Abdelrahman Y Fouda, Bindu Pillai, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|July 1, 1987
Antihypertensive effects of parenteral nicardipine alone and in combination with captoprilK A Conrad, T C Fagan, P Mayshar, et al.
Pharmacotherapy|March 24, 2006
Minocycline for short-term neuroprotectionHazem F Elewa, Hend Hilali, David C Hess, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetesWeiguo Li, Aisha I Kelly-Cobbs, Erin M Mezzetti, et al.
Stroke|August 8, 2013
Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recoveryRoshini Prakash, Weiguo Li, Zhi Qu, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|August 1, 1979
Presystemic and systemic glucuronidation of propranololT Walle, T C Fagan, E C Conradi, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Talanta|October 31, 2008
Modification of micro-cantilever sensors with sol-gels to enhance performance and immobilize chemically selective phasesB C Fagan, C A Tipple, Z Xue, et al.
Annals of Emergency Medicine|May 29, 2012
A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic strokeDenise M Boudreau, Greg Guzauskas, Kathleen F Villa, et al.
Journal of Hypertension|October 12, 2014
Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic strokeAhmed Alhusban, Abdelrahman Y Fouda, Bindu Pillai, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|July 1, 1987
Antihypertensive effects of parenteral nicardipine alone and in combination with captoprilK A Conrad, T C Fagan, P Mayshar, et al.
Pharmacotherapy|March 24, 2006
Minocycline for short-term neuroprotectionHazem F Elewa, Hend Hilali, David C Hess, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetesWeiguo Li, Aisha I Kelly-Cobbs, Erin M Mezzetti, et al.
Stroke|August 8, 2013
Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recoveryRoshini Prakash, Weiguo Li, Zhi Qu, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|August 1, 1979
Presystemic and systemic glucuronidation of propranololT Walle, T C Fagan, E C Conradi, et al.
Pageof 26